Literature DB >> 11232601

Oxygen free radicals and excitation-contraction coupling.

J I Goldhaber1, M S Qayyum.   

Abstract

Oxygen free radicals (OFR) contribute to contractile failure, rigor, and calcium (Ca2+) overload in ischemic/reperfused myocardium. Using both multicellular and isolated single-cell preparations, our laboratory has identified two fundamental mechanisms contributing to the deleterious effects of OFR: (i) impaired myocardial metabolism, and (ii) altered myocardial calcium handling. Impaired metabolism leads to activation of metabolically sensitive K+ currents, which shorten the action potential, thereby decreasing the duration of systole. Ultimately, high-energy phosphate depletion secondary to metabolic failure results in rigor. Altered myocardial Ca2+ handling is evidenced by a decrease in Ca2+ entry via L-type Ca2+ channels [another cause of decreased action potential duration (APD)], a reduction in sarcoplasmic reticulum (SR) Ca2+ content, slowed Ca2+ uptake in diastole, and increased sodium-calcium exchange (NaCaX) activity. The increase in NaCaX activity may contribute to the early increase in developed tension frequently observed in multicellular preparations exposed to free radicals, as well as the SR depletion occurring early on in voltage-clamped isolated cell preparations. Increased NaCaX activity is likely to be a critical factor underlying the late Ca2+ overload that occurs in the setting of increased intracellular Na+, and which leads to irreversible injury. The extent to which free radical-mediated metabolic inhibition participates in the dysfunction of the L-type Ca2+ channel is uncertain. The altered activity of the SR Ca2+ pump and NaCaX are more likely caused by direct actions of OFR on these proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11232601     DOI: 10.1089/ars.2000.2.1-55

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  32 in total

1.  Redox modulation of basal and beta-adrenergically stimulated cardiac L-type Ca(2+) channel activity by phenylarsine oxide.

Authors:  Carl Sims; Robert D Harvey
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

2.  Cyclooxygenase-2 inhibition improves antioxidative defense during experimental hypercholesterolemia.

Authors:  Sagheer Ahmed; Saima Gul; Humera Gul; Muhammad Zia-Ul-Haq; Sezai Ercisli
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

3.  AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction.

Authors:  Subat Turdi; Xiujuan Fan; Ji Li; Junxing Zhao; Anna F Huff; Min Du; Jun Ren
Journal:  Aging Cell       Date:  2010-05-10       Impact factor: 9.304

4.  Enhanced Na+/H+ exchange during ischemia and reperfusion impairs mitochondrial bioenergetics and myocardial function.

Authors:  Mohammed Aldakkak; David F Stowe; James S Heisner; Marisha Spence; Amadou K S Camara
Journal:  J Cardiovasc Pharmacol       Date:  2008-09       Impact factor: 3.105

Review 5.  Pathophysiology and pathogenesis of post-resuscitation myocardial stunning.

Authors:  Athanasios Chalkias; Theodoros Xanthos
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

6.  Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: Roles of Akt, mTOR, GSK3beta, and PTEN.

Authors:  Bingfang Zhang; Subat Turdi; Quan Li; Faye L Lopez; Anna R Eason; Piero Anversa; Jun Ren
Journal:  Free Radic Biol Med       Date:  2010-08-01       Impact factor: 7.376

Review 7.  Neuronal calcium homeostasis and dysregulation.

Authors:  Marc Gleichmann; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-11-30       Impact factor: 8.401

8.  Cardiac-specific overexpression of metallothionein rescues nicotine-induced cardiac contractile dysfunction and interstitial fibrosis.

Authors:  Nan Hu; Rui Guo; Xuefeng Han; Baocheng Zhu; Jun Ren
Journal:  Toxicol Lett       Date:  2011-01-14       Impact factor: 4.372

9.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

10.  Malondialdehyde inhibits cardiac contractile function in ventricular myocytes via a p38 mitogen-activated protein kinase-dependent mechanism.

Authors:  David V Folden; Akanksha Gupta; Avadhesh C Sharma; Shi-Yan Li; Jack T Saari; Jun Ren
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.